The new AI from the Fitbit founders promises family health tracking, but the real play is centralized data control and predictive modeling.
AI scribes are flooding healthcare, but the real story isn't efficiency—it's data capture and physician burnout transfer. Analyze the hidden costs.
Forget wearables. The true convergence of immersive gaming, AI, and healthcare is here. But the hidden cost of this 'digital pill' revolution is data ownership.
Forget better wellness plans. The real battle for **AI in healthcare** isn't about accuracy—it's about data ownership and algorithmic bias in **personalized medicine**.
Pharma stocks are surging on AI partnerships, but the unspoken truth is that this tech infusion might just cement oligopolies and inflate future drug prices.
Anthropic is pushing Claude into life sciences, but the real story isn't better diagnoses—it's who controls the new medical intelligence bottleneck.
Anthropic is pushing Claude into healthcare, but the real battle isn't clinical success; it’s controlling the future of proprietary medical data.
OpenAI’s ChatGPT Health launch is here. But beyond the hype, this move signals a massive power shift in medical AI, threatening independent practitioners.
Google's sudden halt on AI health summaries isn't about minor safety bugs; it's a calculated retreat from catastrophic legal exposure in the high-stakes world of digital health.
OpenAI's entry into healthcare isn't about better diagnoses; it's a calculated move to shift medical accountability. We analyze the real winners and losers in this AI power grab.
Lumos AI promises precision in mental health drugs, but who really profits? Unpacking the dark side of AI in psychiatric drug development.
OpenAI's ChatGPT Health launch isn't about patient care; it's about data acquisition. Unpacking the real winners in this new era of AI diagnostics.